Biotricity Inc. (OTCQB: BTCY) announced on November 13, 2024, that it expects to report a shift to positive Adjusted EBITDA for its second quarter of fiscal year 2025.
The company stated that this represents its best financial performance to date, highlighting improvements in margins and operational efficiency. This milestone indicates progress towards sustained profitability.
This pre-announcement provides investors with an early positive signal regarding the company's financial trajectory. It underscores management's focus on cost control and revenue growth initiatives.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.